Screening and Rational Design of Hepatitis C Virus Entry Inhibitory Peptides Derived from GB Virus A NS5A

Chronic infection by hepatitis C virus (HCV) is a cause of the global burden of liver diseases. HCV entry into hepatocytes is a complicated and multistep process that represents a promising target for antiviral intervention. The recently reported amphipathic α-helical virucidal peptide (C5A) from th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Liu, Xiuying, Huang, Yibing, Cheng, Min, Pan, Ling, Si, Youhui, Li, Guirong, Niu, Yuqiang, Zhao, Lianjing, Zhao, Jin, Li, Xiang, Chen, Yuxin, Yang, Wei
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2013
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3554153/
https://ncbi.nlm.nih.gov/pubmed/23175359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.02201-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados